Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
GENKORD logo — A cord blood and stem cell bank that enhances medical resear...

GENKORD

A cord blood and stem cell bank that enhances medical research and treatment by preserving valuable stem cells from newborns.

Founded 2003 Turkey Turkey 18 employees Biotechnology, Banking

General Information

Company Name GENKORD
Founded Year 2003
Location Turkey Turkey
Employees 18
Industries Biotechnology, Banking
Business Model D2C, B2C, B2B
Revenue Model Subscription, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with GENKORD. To contact GENKORD, visit genkord.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GENKORD compare?

A PDF of GENKORD and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GENKORD soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GENKORD

GENKORD, founded in 2003, is a pioneering biotechnology entity operating in the niche sector of cord blood and stem cell banking. The company, based in Turkey, specializes in enhancing medical research and treatment through its focus on preserving valuable stem cells from newborns.

The firm's contributions to biotechnology research are bolstered through collaborations with numerous renowned institutions and scientists. Notably, GENKORD has received support from Tübitak and engaged in tissue engineering initiatives with the Hacettepe University Bioengineering Department. Additionally, it offers cryopreservation services tailored to specific needs, reflecting its versatility and commitment to advancing medical sciences.

Operating in the intersection of Biotechnology and Banking, the company remains a promising venture for investors interested in biotech advancements. However, it's noteworthy that GENKORD hasn't attracted recent investments, which could be a focal point for potential funding strategies and future growth opportunities.

Business keywords: cord blood banking, stem cell preservation, tissue engineering, cryopreservation, medical research, regenerative medicine, Tübitak collaboration, Hacettepe University partnership, umbilical cord blood, umbilical cord tissue, fibroblast applications, dental stem cells, biomedical research, customized preservation solutions

Services & Products

Cord Blood and Tissue Banking
Stem Cell Laboratory Services
Immunotherapy
Regenerative Medicine Research

Target Customers

Patients with Chronic Diseases Expectant Parents Healthcare Providers Research Institutions

No funding data available for GENKORD yet.

FAQ About GENKORD

A cord blood and stem cell bank that enhances medical research and treatment by preserving valuable stem cells from newborns.
GENKORD was founded in 2003.
GENKORD is headquartered in Turkey.
GENKORD operates in Biotechnology and Banking. Its work centres on cord blood banking, stem cell preservation, tissue engineering and cryopreservation. Its customers include Patients with Chronic Diseases, Expectant Parents and Healthcare Providers.
GENKORD has a D2C, B2C and B2B business model. Its revenue comes from Subscription and Service Fee.
GENKORD has approximately 18 employees.
GENKORD offers: Cord Blood and Tissue Banking, Stem Cell Laboratory Services, Immunotherapy, Regenerative Medicine Research.

We're actively collecting intelligence on GENKORD.

Source: BounceWatch company record for GENKORD, https://bouncewatch.com/company/genkord, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout